Corrigendum: Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1

In the article “Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1” which appeared in vol. 133, issue 7, page 853 of Chinese Medical Journal,^[1] the authors “Jing Zhao^1,2, Jian Huang^2,3” should be corrected as “Jing Zhao¹, Jian Huang²”, and their affliations “²Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Hangzhou, Zhejiang 310009, China; ³Department of Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China” should be corrected as “²Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, Department of Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China”.